This article provides a detailed methodological and conceptual framework for researchers aiming to investigate the role of SOX9 in tumor-associated macrophages (TAMs).
Combining SOX9 inhibition with PD-1/PD-L1 blockade represents a promising strategy to overcome immunotherapy resistance in solid tumors.
The transcription factor SOX9 emerges as a pivotal, yet dualistic, regulator in cancer biology and tumor immunology.
The transcription factor SOX9 is a critical regulator in development, but its dysregulation in the tumor microenvironment (TME) is increasingly recognized as a pivotal driver of cancer progression.
This article provides a comprehensive resource for researchers and drug development professionals on the application of CRISPR-Cas9 technology for modulating SOX9 in immune cell models.
This article comprehensively examines the dual role of the transcription factor SOX9 in autoimmune and inflammatory disorders.
This article synthesizes current research on the transcription factor SOX9, detailing its complex, dual role as a master regulator of cancer immune evasion and a key player in maintaining tissue...
This review synthesizes current knowledge on the transcription factor SOX9, highlighting its complex, dual role in inflammatory diseases and tissue repair.
The transcription factor SOX9 is a pivotal, yet dualistic, regulator of the tumor immune microenvironment.
This article synthesizes current knowledge on the transcription factor SOX9 as a pivotal regulator in T cell differentiation and function.